These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4065184)

  • 21. Plasma high-density lipoprotein cholesterol in epileptics treated with various anticonvulsants.
    Luoma PV; Myllylä VV; Sotaniemi EA; Lehtinen IA; Hokkanen EJ
    Eur Neurol; 1980; 19(1):67-72. PubMed ID: 7371656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible induction of cholinesterase in epileptic patients treated with anticonvulsant drugs: relationship with lipoprotein levels.
    Tutor-Crespo MJ; Hermida J; Tutor JC
    J Clin Pharmacol; 2004 Sep; 44(9):974-80. PubMed ID: 15317825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in plasma activities of lipolytic enzymes and lipids of normolipidemic subjects given phenobarbital, a strong microsomal inducer, alone or in combination with fenofibrate.
    Heller FR; Desager JP; Harvengt C
    Int J Clin Pharmacol Ther Toxicol; 1988 Mar; 26(3):138-42. PubMed ID: 3410596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the effects of propylthiouracil, amiodarone, diphenylhydantoin, phenobarbital, and 3-methylcholanthrene on hepatic and renal T4 metabolism and thyroid gland function in rats.
    De Sandro V; Chevrier M; Boddaert A; Melcion C; Cordier A; Richert L
    Toxicol Appl Pharmacol; 1991 Nov; 111(2):263-78. PubMed ID: 1957312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased high-density lipoprotein cholesterol in patients with epilepsy treated with carbamazepine: a gender-related study.
    Sudhop T; Bauer J; Elger CE; von Bergmann K
    Epilepsia; 1999 Apr; 40(4):480-4. PubMed ID: 10219275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-density lipoproteins and hepatic microsomal enzyme induction in alcohol consumers.
    Luoma PV; Sotaniemi EA; Pelkonen RO; Ehnholm C
    Res Commun Chem Pathol Pharmacol; 1982 Jul; 37(1):91-6. PubMed ID: 7123003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevalence of cardiovascular risk factors in coronary heart disease patients with different low-density lipoprotein phenotypes].
    Slapikas R; Luksiene D; Slapikiene B; Babarskiene MR; Grybauskiene R; Linoniene L
    Medicina (Kaunas); 2005; 41(11):925-31. PubMed ID: 16333215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective liver enzyme induction by carbamazepine and phenytoin in Chinese epileptics.
    Tomlinson B; Young RP; Ng MC; Anderson PJ; Kay R; Critchley JA
    Eur J Clin Pharmacol; 1996; 50(5):411-5. PubMed ID: 8839665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and regression of the hepatic microsomal enzyme induction and stimulation of biliary excretion produced by phenobarbital in rats.
    Fischer E; Gregus Z
    Arch Int Pharmacodyn Ther; 1980 Oct; 247(2):190-7. PubMed ID: 7447565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding of anticonvulsant drugs to cytochrome P-450: correlation with evidence of induction of hepatic microsomal enzymes.
    Latham AN; Sweeney GD
    Can J Physiol Pharmacol; 1976 Dec; 54(6):844-9. PubMed ID: 1021219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy.
    Nikolaos T; Stylianos G; Chryssoula N; Irini P; Christos M; Dimitrios T; Konstantinos P; Antonis T
    Med Sci Monit; 2004 Apr; 10(4):MT50-2. PubMed ID: 15039653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of antiepileptic drugs on plasma lipids, lipoprotein (a), and liver enzymes.
    Sonmez FM; Demir E; Orem A; Yildirmis S; Orhan F; Aslan A; Topbas M
    J Child Neurol; 2006 Jan; 21(1):70-4. PubMed ID: 16551457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevation of high-density lipoprotein in epileptic patients treated with phenytoin.
    Nikkilä EA; Kaste M; Ehnholm C; Viikari J
    Acta Med Scand; 1978; 204(6):517-20. PubMed ID: 216240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.
    Manninen V; Tenkanen L; Koskinen P; Huttunen JK; Mänttäri M; Heinonen OP; Frick MH
    Circulation; 1992 Jan; 85(1):37-45. PubMed ID: 1728471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of oral ethanol on serum lipoprotein cholesterol in juvenile meat-type chickens.
    Peebles ED; Latour MA; Broome-Cheaney SE; Cheaney JD; Zumwalt CD
    Alcohol; 1996; 13(2):111-5. PubMed ID: 8814643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood rheology and the low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio in dyslipidaemic and normolipidaemic subjects.
    Machida T; Sumino H; Fukushima M; Kotajima N; Amagai H; Murakami M
    J Int Med Res; 2010; 38(6):1975-84. PubMed ID: 21227001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of risk factors on peripheral and cerebrovascular disease in men with coronary artery disease, low high-density lipoprotein cholesterol levels, and desirable low-density lipoprotein cholesterol levels. HIT Investigators. Department of Veterans Affairs HDL Intervention Trial.
    Papademetriou V; Narayan P; Rubins H; Collins D; Robins S
    Am Heart J; 1998 Oct; 136(4 Pt 1):734-40. PubMed ID: 9778079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum lipid levels during carbamazepine medication. A prospective study.
    Isojärvi JI; Pakarinen AJ; Myllylä VV
    Arch Neurol; 1993 Jun; 50(6):590-3. PubMed ID: 8099275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.